Latest Information Update: 07 Jan 2015
At a glance
- Originator APEPTICO Forschung und Entwicklung
- Developer APEPTICO Forschung und Entwicklung; University of Vienna
- Class Peptides
- Mechanism of Action Sodium channel agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Research Pseudohypoaldosteronism
Most Recent Events
- 02 Jan 2015 Early research in Pseudohypoaldosteronism in Austria (Inhalation)